Company Filing History:
Years Active: 2012
Title: Amanda Jane Lyons: Innovator in Pharmaceutical Chemistry
Introduction
Amanda Jane Lyons is a notable inventor based in Newhouse, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target AMPA receptors. Her work is crucial in addressing psychiatric diseases and enhancing synaptic responses.
Latest Patents
Amanda holds a patent for "Substituted thieno[2,3-d]pyrimidines as AMPA modulators." This invention relates to a heterocyclic derivative, which is defined by specific variables in the patent specification. The invention also encompasses pharmaceutically acceptable salts or solvates of these derivatives. Furthermore, it includes a pharmaceutical composition that utilizes these heterocyclic derivatives for therapeutic purposes, particularly in treating psychiatric conditions such as schizophrenia, depression, and memory disorders like Alzheimer's disease. Amanda has 1 patent to her name.
Career Highlights
Amanda is currently associated with MSD Oss B.V., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving mental health treatments through scientific advancements.
Collaborations
Amanda has collaborated with notable colleagues, including Michael Gerard Gallagher and Craig Jamieson, who contribute to her research endeavors.
Conclusion
Amanda Jane Lyons exemplifies the spirit of innovation in pharmaceutical chemistry, with her work paving the way for advancements in the treatment of psychiatric diseases. Her contributions are vital for the future of mental health therapies.